MedPath

Audition After a Lesion and in Migraine. (AuditionPostLesion)

Not Applicable
Completed
Conditions
Migraine Disorders, Brain
Registration Number
NCT02791997
Lead Sponsor
Hospices Civils de Lyon
Brief Summary

The project studies auditory processing after brain damage (in temporal and/or frontal areas) and in migraine. The auditory processes investigated are attention, short-term memory, sound-induced emotions. To characterize auditory deficits after brain damage or in migraine, neuropsychological assessments are combined with neurophysiological markers (Electro-encephalography: EEG, Magneto-encephalography: MEG, Magnetic Resonance Imaging: MRI).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
262
Inclusion Criteria
  • Age from 18 to 80
  • MEG/MRI compatibility
  • Motivation to participate efficiently in the study
  • No severe hearing loss
  • Informed consent to participate in the study
  • Affiliation to social security
  • For brain-damaged patients : no need for medical assistance; focal temporal and/or frontal lesion; no major cognitive impairment; ability to understand and apply the instructions for neuropsychological testing; testing at least one-month after the event resulting in brain damage; absence of neurological and psychiatric disorders besides the lesion
  • For migraine patients: no need for medical assistance; migraine diagnosis; no major cognitive impairment; ability to understand and apply the instructions for neuropsychological testing; absence of neurological and psychiatric disorders besides the migraine
  • Healthy participants: absence of neurological and psychiatric disorders
Exclusion Criteria
  • Age below 18 or above 80
  • MRI scanning not possible: artificial cardiac pacemaker, insulin pump, metallic prosthesis, intra-cerebral clip, claustrophobia
  • MEG acquisition not possible: large heads, neurostimulator, metal in the head or the body.
  • Pregnant or breast-feeding women

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Percentages of correct responses in Neuropsychological testsup to 2 months
reaction times in Neuropsychological testsup to 2 months
Secondary Outcome Measures
NameTimeMethod
Event-Related Fields (MEG) in Neurophysiological testsup to 2 months
Event-Related Potentials (EEG) in Neurophysiological testsup to 2 months

Trial Locations

Locations (2)

Unité 201, Hôpital Neurologique

🇫🇷

Bron, France

Service Explorations Fonctionnelles Neurologiques, Hôpital de la Croix-Rousse

🇫🇷

Lyon, France

Unité 201, Hôpital Neurologique
🇫🇷Bron, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.